Most admired pharma companies in Japan, by IAL

7 March 2012

Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey to determine the most admired pharma companies in Japan. Each year, IAL evaluates 30 companies, 15 Japanese and 15 foreign affiliated firms. In 2011 it included the firms listed below:

Japanese
Ajinomoto, Astellas, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Kyowa Hakko Kirin, Meiji Seika, Mitsubishi Tanabe, Nippon Shinyaku, Ono, Otsuka, Shionogi, Takeda, Teijin,Torii

Foreign
Abbott, AstraZeneca, Bayer, Bristol-Myers, Chugai (Roche group), Eli Lilly, GlaxoSmithKline, Janssen (J&J group), MSD (Merck & Co), Boehringer Ingelheim, Novartis, Novo Nordisk, Pfizer, sanofi-aventis, UCB

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical